Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Compare high yield versus low fee strategies in dividend investing to determine which factor more strongly influences long-term performance.
27,099 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A Kentucky GOP primary produced a win for a Trump-backed challenger, marking a new chapter in Trump’s hold on the par...
Aging workers and slower inflows of young talent are driving a new 'great mismatch' in the labor market, according to...
Nasdaq secures conditional SEC clearance to list Bitcoin index options, signaling a broader, more regulated derivativ...
JPMorgan Chase unveils a $40 million grant initiative as the first major payout under its American Dream plan, aiming...
A 65-year-old retiree with $2.4 million uncovers a looming $58,000-a-year caregiver bill for an aging parent, prompti...
When a company’s CFO reports a large stock sale, investors want to know what it implies. This article breaks down the...
A prominent smart-money investor boosted bets on Intel as the AI-driven semiconductor rally intensifies. The rest of ...
Gate teams up with Alpaca to offer real stock trading to users worldwide, bridging crypto and traditional markets wit...
Jim Cramer reframes Nokia’s story from a smartphone casualty to an AI infrastructure play, highlighting the stock’s s...
Ukraine intensified pressure on St. Petersburg with a drone barrage as Putin rejected Kyiv's call for talks. The stri...
The Gedalje Group climbs to the top 10 in RealTrends' 2026 The Thousand rankings after closing 468 sides and $245 mil...